Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Go back to Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
Genentech, Inc. (NYSE: DNA) Delayed: 7.89 -0.11 (1.38%)
Previous Close $8.00    52 Week High $99.14 
Open $8.00    52 Week Low $69.17 
Day High $8.20    P/E 2.46 
Day Low $7.76    EPS $3.21 
Volume 697,083